203247-10-3Relevant academic research and scientific papers
Arylsulphonyl hydroxamic acids: Potent and selective matrix metalloproteinase inhibitors
Baxter, Andrew D,Bhogal, Ranjev,Bird, John,Keily, John F,Manallack, David T,Montana, John G,Owen, David A,Pitt, William R,Watson, Robert J,Wills, Ruth E
, p. 1465 - 1468 (2007/10/03)
A series of novel matrix metalloproteinase inhibitors is described in which selectivity between MMP and 'sheddase' activity has been achieved and which demonstrate potent in vivo activity in models of arthritis and cancer.
